Chinese case study suggests COVID-19 is not transmitted from pregnant mothers to newborns
FrontiersFinally, some good news has emerged about the novel coronavirus that has spread to about 50 countries across the world.
Finally, some good news has emerged about the novel coronavirus that has spread to about 50 countries across the world.
A noblewoman from Imperial China enjoyed playing polo on donkeys so much she had her steeds buried with her so she could keep doing it in the afterlife, archaeologists found. This discovery by a team that includes Fiona Marshall, the James W. and Jean L. Davis Professor in Arts & Sciences at Washington University in St. Louis, is published March 17 in the journal Antiquity. The research provides the first physical evidence of donkey polo in Imperial China, which previously was only known from historical texts. It also sheds light on the role for donkeys in the lives of high status women in that period.
Person-to-person transmission of SARS-CoV-2 occurred between two people with prolonged, unprotected exposure while the first patient was symptomatic. Despite active monitoring and testing of 372 contacts of both cases, no further transmission was detected.
A new study, published this week in the International Journal of Health Services, found that older adults without health insurance in China were 35% less likely to receive needed inpatient care compared to those with job-based health insurance.
Researchers at the University of Maryland School of Medicine’s Institute of Human Virology (IHV), which is part of the Global Virus Network (GVN), predict that COVID-19 will follow a seasonal pattern similar to other respiratory viruses like seasonal flu. They base this on weather modeling data in countries where the virus has taken hold and spread within the community.
I am the Director of the Center for the Ecology of Infectious Diseases at the University of Georgia. My colleagues and I have been following COVID-19 since the middle of January. Our analysis of the data leads me to believe that serious action now is imperative.
Being of an older age, showing signs of sepsis, and having blood clotting issues when admitted to hospital are key risk factors associated with higher risk of death from the new coronavirus (COVID-19), according to a new observational study of 191 patients with confirmed COVID-19 from two hospitals in Wuhan, China, published in The Lancet.
How can business, labor, and government collaborate to reduce poverty on regional and global bases? Will the United States-Mexico-Canada Agreement benefit U.S. workers? How will the trade war with China affect the automotive industry? Watch an in-depth, nonpartisan conversation on critical foreign policy challenges facing the winner of the 2020 presidential election. Former government officials from Republican and Democratic administrations will discuss issues central to our national security and answer questions about U.S. policy and America’s role in the world.
“Made in China.” You’ve probably seen this label on your clothes, toys, and other everyday products. China’s reach has skyrocketed in recent decades, disrupting the global trading system as we know it. This video is part of the Inside the Issues video series, featuring CFR Vice President of Studies Shannon K. O’Neil. Watch as she helps explain and clarify common misconceptions surrounding international issues such as China’s trade practices, green jobs, and immigration.
When was the last time you went to the mall for something you could buy on your phone? Automation is a disruptive force that continues to shape the future. CFR breaks down what automation means for the U.S. workforce.
An analysis of publicly available data on infections from the new coronavirus, SARS-CoV-2, that causes the respiratory illness COVID-19 yielded an estimate of 5.1 days for the median disease incubation period, according to a new study led by researchers at Johns Hopkins Bloomberg School of Public Health.
“The new virus originating from Wuhan is the third coronavirus that has made the ‘jump’ from animals to humans,” explains Enrico Bucci, Ph.D., professor and research scientist at the Sbarro Health Research Organization (SHRO), at Temple University in Philadelphia.
n article by radiologists from Wuhan, China--published open-access and ahead-of-print in the American Journal of Roentgenology (AJR)--concluded that chest CT had a low rate of misdiagnosis of COVID-19 (3.9%, 2/51) and could help standardize imaging features and rules of transformation for rapid diagnosis; however, CT remains limited for the identification of specific viruses and distinguishing between viruses.
COVID-19 is similar in symptoms to the seasonal flu, but to recognize it there is a different procedure and we have to act accordingly
FACULTY Q&ARavi Anupindi.Ravi Anupindi is a professor of technology and operations and faculty director for the Center for Value Chain Innovation at the University of Michigan’s Ross School of Business. He discusses how companies can deal with the COVID-19 outbreak.Ravi Anupindi.What can companies do right now to deal with supply chain interruptions?Anupindi: It is important to recognize that virus outbreaks are different from other types of disruptions like fires, floods and earthquakes.
Faculty Q&AAs the coronavirus spreads throughout the country, an increasing number of American health care workers helping to treat patients are contracting the infection.Christopher Friese.Christopher Friese, the Elizabeth Tone Hosmer Professor of Nursing at the School of Nursing and professor of health management and policy at the School of Public Health, leads a research team focused on health care delivery in high-risk settings.
Researchers from Cornell and the Mars Global Food Safety Center can complete whole-genome sequencing to determine salmonella serotypes in two hours and the whole identification process within eight hours.
A Baylor University interior design team is assisting Decon7 Systems — manufacturer of a powerful disinfectant used by the military, first responders and, most recently, hospitals in China as they battle Coronavirus Disease (COVID-19) 19 — in designing a hyperclean play space for children with diseases that compromise their immunity.
A multi-center study (n=101) of the relationship between chest CT findings and the clinical conditions of coronavirus disease (COVID-19) pneumonia--published ahead-of-print and open-access in the American Journal of Roentgenology (AJR)--determined that most patients with COVID-19 pneumonia have ground-glass opacities (GGO) (86.1%) or mixed GGO and consolidation (64.4%) and vascular enlargement in the lesion (71.3%).
While COVID-19, previously known as the novel coronavirus, was first reported in China, it was recently declared a global health emergency by the World Health Organization. Because most cases have been in China, clinicians elsewhere may be unfamiliar with how the virus appears in the lungs.
Dean Headley, co-author of the national Airline Quality Rating from Wichita State University, says public concerns over COVID-19 will mostly negatively affect air travel internationally, but will certainly have some impact on domestic air travel as the virus spreads.
A group of University of Alberta researchers who have discovered why the drug remdesivir is effective in treating the coronaviruses that cause Middle East respiratory syndrome (MERS) and severe acute respiratory syndrome (SARS) expect it might also be effective for treating patients infected with the new COVID-19 strain.
An international team of clinicians and researchers for the first time have described the pathology of the SARS-CoV-2, or coronavirus, and published their findings in the Journal of Thoracic Oncology, the journal of the International Association for the Study of Lung Cancer.
Emergency physician-led teams are on the frontlines of coronavirus treatment, prevention and response.
The emergence and rapid increase in cases of coronavirus disease 2019 (COVID-19), a respiratory illness caused by a novel coronavirus, pose complex challenges to the global public health, research and medical communities, write federal scientists from NIH's National Institute of Allergy and Infectious Diseases (NIAID) and from the Centers for Disease Control and Prevention (CDC).
Although the imaging features of novel coronavirus disease 2019 (COVID-19) are variable and nonspecific, the findings reported thus far do show "significant overlap" with those of severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS), according to an ahead-of-print article in the American Journal of Roentgenology (AJR).
With COVID-19 now spreading via community transmission in the U.S. and the World Health Organization raising its risk assessment to “very high,” the Johns Hopkins Bloomberg School of Public Health will host a 30-minute webcast featuring some of the best minds addressing this global health concern.
Many people are hearing about coronavirus for the first time as the China strain, COVID-19, affecting humans causes concern all across the world. But coronaviruses are not new to livestock and poultry producers, according to a Texas A&M AgriLife veterinary epidemiologist.
Technology can be used to track how the virus evolves over time, how it transmits between people, how well it survives outside the body, and to find answers to other questions.
UAB experts provide tips for you to prepare yourself in the event of the spread of COVID-19.
Findings from CT scans provide new insight that could lead to quicker diagnosis
As of Feb. 25, 2020, the World Health Organization reported 79,339 confirmed cases of novel coronavirus, also known as COVID-19. Thirty-four countries have reported cases, including 2,619 deaths.The WHO has not declared COVID-19 as a pandemic — a situation defined somewhat vaguely by the WHO as “the worldwide spread of a new disease.
Interacting contagious diseases like influenza and pneumonia—and perhaps coronavirus too—follow the same complex spreading patterns as social trends, like the adoption of new slang or technologies. This new finding, published in Nature Physics, could lead to better tracking and intervention when multiple diseases spread through a population at the same time.
Harvard University scientists will collaborate with Chinese colleagues to elucidate the basic biology of the novel coronavirus (COVID-19), and the resulting disease, toward new diagnostic tools, vaccine development and antiviral therapies. The collaboration is part of a $115 million research initiative funded by China Evergrande Group.
Professor James “Mac” Hyman's goal is to help the public health community better understand and predict the spread of the COVID-19 and to quantify the effectiveness of various efforts to stop it.